A5050827047- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes
- Cardiac pacing and defibrillation studies
- Cardiac electrophysiology and arrhythmias
- Cardiovascular Syncope and Autonomic Disorders
- Heart Rate Variability and Autonomic Control
- Cardiac Imaging and Diagnostics
- Social Media in Health Education
- Cardiac Valve Diseases and Treatments
- Cardiovascular and exercise physiology
- Microbial Inactivation Methods
- Cardiovascular Function and Risk Factors
- Potassium and Related Disorders
- Diabetes Treatment and Management
- Pain Management and Treatment
- Migraine and Headache Studies
- Time Series Analysis and Forecasting
- Cerebrovascular and Carotid Artery Diseases
- ECG Monitoring and Analysis
- Non-Invasive Vital Sign Monitoring
- scientometrics and bibliometrics research
- Academic Publishing and Open Access
- Cardiomyopathy and Myosin Studies
- Central Venous Catheters and Hemodialysis
- Heart Failure Treatment and Management
Rzeszów University
2016-2025
Heart Rhythm Society
2020
Krankenhaus der Elisabethinen
2019
Abstract Objective We aimed to assess the effect of SGLT2i on arrhythmias by conducting a meta-analysis using data from randomized controlled trials(RCTs). Background Sodium-glucose co-transporter 2 inhibitors (SGLT2i) have shown cardioprotective effects via multiple mechanisms that may also contribute decrease risk. Methods searched in databases (PubMed, Embase, Cochrane Library, and clinicaltrials.gov) up April 2023. RCTs comparing with placebo were included. The atrial fibrillation(AF),...
Ablation of outflow tract ventricular arrhythmias may be limited by a deep intramural location the arrhythmogenic source. This study evaluates acute and long-term outcomes patients undergoing ablation premature complexes (PVCs).This multicenter series included with structurally normal heart or nonischemic cardiomyopathy PVCs defined by: (a) ≥ 2 following criteria: (1) earliest endocardial epicardial activation < 20ms pre-QRS; (2) Similar in different chambers; (3) no/transient PVC...
Abstract Ventricular tachycardia (VT), and its occurrence, is still one of the main reasons for sudden cardiac death and, therefore, increased mortality morbidity foremost in patients with structural heart [Kahle A-K, Jungen C, Alken F-A, Scherschel K, Willems S, Pürerfellner H et al. Management ventricular ischaemic cardiomyopathy: contemporary armamentarium. Europace 2022;24:538–51]. Catheter ablation has become a safe effective treatment option recurrent VT [Cronin EM, Bogun FM, Maury P,...
Abstract Aims Advanced ablation strategies are needed to treat ventricular tachycardia (VT) and premature complexes (PVC) refractory standard unipolar radiofrequency (Uni-RFA). Bipolar catheter (Bi-RFA) has emerged as a treatment option for VT PVC. Multicentre registry data on the use of Bi-RFA in setting PVC lacking. The aim this is determine its real-world safety, feasibility, efficacy patients with VT/PVC. Methods results Consecutive undergoing at 16 European centres recurring VT/PVC...
Catheter ablation of premature ventricular complexes (PVCs) and tachycardia (VT) from the left summit (LVS) may require advanced techniques. Bipolar coronary veins adjacent endocardial structures can be effective for refractory LVS arrhythmias.
Stereotactic arrhythmia radioablation (STAR) is a treatment option for recurrent ventricular tachycardia/fibrillation (VT/VF) in patients with structural heart disease (SHD). The current and future role of STAR as viewed by cardiologists unknown. study aimed to assess the role, barriers application, expected STAR. An online survey consisting 20 questions on baseline demographics, awareness/access, use, was conducted. A total 129 international participants completed [mean age 43 ± 11 years,...
Lifestyle and risk factor modification (LRFM) forms a central pillar in the management of atrial fibrillation (AF). This European Heart Rhythm Association (EHRA) survey aims to assess current clinical practice regarding LRFM across EHRA countries. A 31-item questionnaire was developed distributed amongst healthcare professionals via social media, between 23rd September 21st October 2024. Of 258 respondents from 28 countries, 39.9% reported that their system is badly or very designed deliver...
Abstract Introduction Bipolar radiofrequency catheter ablation (Bi‐RFCA) emerged as an option for treatment of arrhythmias resistant to the conventional approach. Data on safety issues Bi‐RFCA, including temperature values intracardiac return electrode (IRE) are lacking. Objective To determine profile Bi‐RFCA regarding measurements obtained from nonirrigated IRE different sizes. Methods The study group consisted consecutive patients after failed RFCA who underwent Bi‐RFCA. Results Out 1510...
Catheter ablation (CA) is recommended for patients with atrial fibrillation (AF) after failure of antiarrhythmic drugs (AADs). The role CA as 'initial therapy' AF to be determined.Following PRISMA guideline an up-to-date pooled analysis randomized data comparing vs. AADs first-line therapy symptomatic was performed. primary outcome recurrence tachyarrhythmia. secondary outcomes were improvement in quality-of-life (QoL) and major adverse events. A total 997 from five trials enrolled (mean age...
Cardioneuroablation (CNA) is a catheter-based intervention for recurrent vasovagal syncope (VVS) that consists in the modulation of parasympathetic cardiac autonomic nervous system. This survey aims to provide comprehensive overview current CNA utilization Europe.
endocardium failed.Mapping of the great cardiac vein performed with an irrigated ablation catheter (AC) showed earliest activation in epicardial area LVS.A second 4-mm AC, which served a return (RC), was introduced into LV outflow tract endocardial PVC activation, and connected to modified purpose-made switchbox order connect tip electrode (instead dispersive patch) B ipolar radiofrequency (RFCA) is emerging option for treatment arrhythmias resistant standard unipolar attempts.A 43-yearold...